Third complementarity determining region (CDR III) sequence analysis in childhood B-lineage acute lymphoblastic leukaemia: implications for the design of oligonucleotide probes for use in monitoring minimal residual disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples